Apixaban Should Be Held 24 Hours Before Minor Low-Bleeding-Risk Procedures
For an adult with normal renal function undergoing a minor procedure, hold apixaban for 24 hours (skip 2 doses) before the procedure. This means the last dose should be taken approximately 24 hours prior to the scheduled intervention 1, 2.
Procedural Risk Classification
Minor procedures are defined as those with:
- Low frequency of bleeding
- Minor impact if bleeding occurs
- Easily controllable bleeding
- Examples: simple dental procedures, minor dermatologic procedures, cataract surgery 1
Specific Timing Recommendations
For Normal Renal Function (CrCl ≥80 mL/min):
- Last apixaban dose: 24 hours before procedure
- Practical approach: Skip 2 doses (since apixaban is dosed twice daily)
- Alternative scheduling: Some guidelines suggest scheduling the procedure 18-24 hours after the last dose for practical purposes 1
Renal Function Adjustments:
If renal impairment exists, longer interruption periods are required:
- CrCl 50-79 mL/min: 24 hours (same as normal function) 1
- CrCl 30-49 mL/min: 24 hours for low-risk procedures 1
- CrCl 15-29 mL/min: 36 hours or more 1
FDA Label Guidance
The official Eliquis (apixaban) prescribing information states: "ELIQUIS should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled" 2. This aligns with the guideline recommendations and provides regulatory support for the 24-hour interruption.
Pharmacokinetic Rationale
This 24-hour interruption corresponds to approximately 2 elimination half-lives of apixaban (which has a half-life of ~12 hours) 2. This allows for sufficient drug clearance while maintaining a balance between bleeding and thrombotic risk for low-risk procedures 3.
Important Caveats
Drug interactions: If the patient is taking combined P-gp and strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavaban, dronedarone, amiodarone, or verapamil), consider adding an extra 24 hours of interruption, especially if thrombotic risk is not very high 1.
Very minor procedures: For truly minimal-risk procedures where bleeding is easily controllable, some guidelines suggest the procedure can be performed at trough levels (12-24 hours after last intake) or even without interruption 1. However, the conservative 24-hour approach remains standard.
No bridging required: Bridging anticoagulation with heparin is NOT recommended or necessary for apixaban interruption 1, 2.
Resumption After Procedure
Restart apixaban 6 hours after the minor procedure once hemostasis is achieved, which effectively means skipping one dose 1. The 2024 AHA/ACC guidelines suggest resuming after hemostasis is established, typically within 24 hours for low-bleeding-risk procedures 4.